Pushing the boundaries: The current status of ABO-incompatible cardiac transplantation

Claire Irving, Andrew Gennery, Richard Kirk

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Since the introduction of intentional ABO-incompatible (ABOi) cardiac transplantation in infants in the late 1990's, the number of patients listed for and undergoing ABOi transplants has increased. This practice has been shown to lead to a reduction in waiting list mortality and increased utilisation of donor organs with equivalent outcomes to ABO-compatible transplants. Differences in the infant immune system provide a window of opportunity for ABOi transplantation. However it is increasingly clear that older patients and those with significant amounts of blood group antibody specific isohaemagglutinins may also benefit. Newer research is now focussing on longer term outcomes of ABOi transplants - in particular the development of graft accommodation or tolerance. This review assesses the current status of ABO-incompatible cardiac transplantation both in infants and in sensitized and older patients.

Original languageEnglish (US)
Pages (from-to)791-796
Number of pages6
JournalJournal of Heart and Lung Transplantation
Issue number8
StatePublished - Aug 2012


  • ABO-incompatible
  • cardiac transplantation
  • infants
  • isohaemagglutinins
  • outcomes

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation


Dive into the research topics of 'Pushing the boundaries: The current status of ABO-incompatible cardiac transplantation'. Together they form a unique fingerprint.

Cite this